1. Home
  2. ECOR vs PPBT Comparison

ECOR vs PPBT Comparison

Compare ECOR & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo electroCore Inc.

ECOR

electroCore Inc.

N/A

Current Price

$6.49

Market Cap

50.0M

Sector

Health Care

ML Signal

N/A

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

N/A

Current Price

$4.22

Market Cap

45.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ECOR
PPBT
Founded
2005
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.0M
45.3M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
ECOR
PPBT
Price
$6.49
$4.22
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
49.2K
80.9K
Earning Date
04-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
53.51
N/A
EPS
N/A
N/A
Revenue
$25,182,000.00
N/A
Revenue This Year
$28.92
N/A
Revenue Next Year
$32.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
57.09
N/A
52 Week Low
$4.16
$0.41
52 Week High
$13.81
$5.18

Technical Indicators

Market Signals
Indicator
ECOR
PPBT
Relative Strength Index (RSI) 46.83 77.72
Support Level $4.64 $0.57
Resistance Level $6.61 N/A
Average True Range (ATR) 0.70 0.27
MACD -0.06 0.37
Stochastic Oscillator 25.73 79.88

Price Performance

Historical Comparison
ECOR
PPBT

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: